STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare (ALHC) awards 122,807 RSUs to EVP Konowiecki

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare EVP Corporate Affairs Joseph S. Konowiecki received a grant of 122,807 restricted stock units of common stock. The award was made at no cash cost to him and is compensation-related rather than an open‑market purchase.

Each restricted stock unit represents one share of Alignment Healthcare common stock. The units will vest in three roughly equal installments on March 13, 2027, March 13, 2028 and March 13, 2029, as long as he continues serving the company on those dates. After this grant, he directly holds 1,203,816 shares of common stock.

Positive

  • None.

Negative

  • None.

Insights

Executive received time-based RSU grant that modestly increases direct equity stake.

Executive vice president Joseph S. Konowiecki was awarded 122,807 restricted stock units, each convertible into one common share, with no exercise price. This is a standard equity compensation grant rather than a market transaction and reflects typical long-term incentive design.

The RSUs vest in three equal annual tranches on March 13, 2027, March 13, 2028 and March 13, 2029, contingent on continued service. Following the grant, his direct holdings total 1,203,816 shares, indicating he maintains a sizable equity position aligned with shareholders.

Insider KONOWIECKI JOSEPH S
Role EVP, Corporate Affairs
Type Security Shares Price Value
Grant/Award Common Stock 122,807 $0.00 $0.00
Holdings After Transaction: Common Stock — 1,203,816 shares (Direct)
Footnotes (1)
  1. F1. Represents 122,807 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.
RSU grant size 122,807 restricted stock units Award of common stock units to EVP Corporate Affairs
Grant price $0.00 per share Compensation-related award, no cash paid by insider
Post-grant holdings 1,203,816 shares Total common shares directly held after the transaction
First vesting date March 13, 2027 First one-third of RSUs vest, subject to continued service
Final vesting date March 13, 2029 Final one-third of RSUs vest, subject to continued service
restricted stock units financial
"Represents 122,807 restricted stock units, each restricted stock unit representing the right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting financial
"that will vest approximately one third on each of March 13, 2027, 2028 and 2029"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continued service financial
"subject to the reporting person's continued service to the Company as of the applicable vesting date"
common stock financial
"the right to receive one share of Common Stock of the Company"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Alignment Healthcare (ALHC) executive Joseph Konowiecki receive in this Form 4?
Joseph S. Konowiecki, EVP Corporate Affairs at Alignment Healthcare, received 122,807 restricted stock units. Each unit represents one share of common stock, granted as equity compensation rather than through an open-market purchase.

How do the 122,807 RSUs for ALHC vest for Joseph Konowiecki?
The 122,807 restricted stock units vest in three approximately equal installments. Vesting occurs on March 13, 2027, March 13, 2028 and March 13, 2029, provided Joseph Konowiecki continues serving Alignment Healthcare on each vesting date.

What is Joseph Konowiecki’s total Alignment Healthcare shareholding after this grant?
After receiving the 122,807 restricted stock units, Joseph Konowiecki directly holds 1,203,816 shares of Alignment Healthcare common stock. This total reflects his position following the reported award in the Form 4 insider transaction filing.

Did Joseph Konowiecki buy or sell ALHC shares in the market in this filing?
He did not buy or sell shares on the open market. The Form 4 reports a compensation-related award of 122,807 restricted stock units at a price of $0.00 per share, rather than any market purchase or sale transaction.

What does a Form 4 equity grant mean for Alignment Healthcare (ALHC) investors?
This Form 4 shows a routine equity compensation grant to an executive, aligning his interests with shareholders through additional stock-based incentives. It does not represent a market trade or a change in company fundamentals by itself.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KONOWIECKI JOSEPH S
(Last)(First)(Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CALIFORNIA 92868
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
EVP, Corporate Affairs
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A122,807(1)A$01,203,816D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents 122,807 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of March 13, 2027, 2028 and 2029, subject to the reporting person's continued service to the Company as of the applicable vesting date.
Remarks:
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Joseph S. Konowiecki06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR